Regulating a Miracle Drug: GLP-1 Costs, Access, & Safety Understanding GLP-1 Drugs: Cost, Safety, and Access in Context New Weight Loss Drugs (GLP-1s) Explained: Science, Impact, Potential Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders Disclaimer: The information provided on this website is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
Wegovy, Mounjaro, and Zepbound are supplied as single-use prefilled pens (though in some cases, other forms, such as single-dose vials, may be available directly from the manufacturer)
Elizabeth Wood hasn't had any negative side effects
Chief Judge Daniel Domenico said Amgen would face significant and irreparable harm because of the price cap, and found that federal patent law likely preempted a state price cap, reported Reuters
Singh RR, Reindl KM